Puma Biotechnology, Inc.PBYINASDAQ
Loading
Year-over-year book value per share growth
Percentile
P62
Within normal range
vs 2Y Ago
0.3x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.08% |
| Q3 2025 | 8.68% |
| Q2 2025 | 7.61% |
| Q1 2025 | 4.35% |
| Q4 2024 | 29.36% |
| Q3 2024 | 44.40% |
| Q2 2024 | -5.05% |
| Q1 2024 | -5.77% |
| Q4 2023 | 37.71% |
| Q3 2023 | 25.40% |
| Q2 2023 | 17.30% |
| Q1 2023 | 17.51% |
| Q4 2022 | -2.99% |
| Q3 2022 | 10.99% |
| Q2 2022 | 158.77% |
| Q1 2022 | 383.69% |
| Q4 2021 | 77.70% |
| Q3 2021 | -135.67% |
| Q2 2021 | 83.77% |
| Q1 2021 | 370.68% |
| Q4 2020 | -1221.67% |
| Q3 2020 | -101.92% |
| Q2 2020 | 148.69% |
| Q1 2020 | -46.64% |
| Q4 2019 | 1.26% |
| Q3 2019 | -21.72% |
| Q2 2019 | -50.05% |
| Q1 2019 | 25.79% |
| Q4 2018 | -25.59% |
| Q3 2018 | 19.18% |
| Q2 2018 | -33.55% |
| Q1 2018 | 7.26% |
| Q4 2017 | -33.21% |
| Q3 2017 | -34.48% |
| Q2 2017 | -28.37% |
| Q1 2017 | -22.89% |
| Q4 2016 | 109.58% |
| Q3 2016 | -28.28% |
| Q2 2016 | -22.99% |
| Q1 2016 | -20.02% |